| Unknown | Post-marketing Safety and Efficacy Surveillance of Motherwort Injection Bleeding, Real-world Study, Adverse Events | — | 2024-10-15 |
| Unknown | Yinhu Qingwen Granule in the Treatment of Viral Pneumonia Viral Pneumonia | EARLY_Phase 1 | 2022-12-01 |
| Suspended | Yinhu Qingwen Granula for the Treatment of Severe CoVID-19 COVID-19, Severe Pneumonia, Chinese Medicine | Phase 2 / Phase 3 | 2021-11-01 |
| Unknown | Effect of Zhuli Capsule on Phlegm-heat Syndrome (Tan-re Zheng) Chronic Obstructive Pulmonary Disease, Chronic Bronchitis | Phase 4 | 2021-07-01 |
| Unknown | Qingfei Granule for the Treatment of the Pediatric Acute Upper Respiratory Tract Infection With Bacterial Infe Upper Respiratory Tract Infection, Bacterial Infection, Chinese Medicine | EARLY_Phase 1 | 2020-10-17 |
| Unknown | Post-marketing Safety Surveillance of Qizhi Tongluo Capsules:a Registry Study. Safety Surveillance, Adverse Drug Events, Adverse Drug Reactions | — | 2020-08-17 |
| Unknown | Xuefu-Zhuyu Capsule for the Treatment of "Qizhi Xueyu Zheng" (Qi Stagnation and Blood Stasis Syndrome) Chinese Medicine, Stable Coronary Heart Disease, Chronic Insomnia | Phase 4 | 2019-12-31 |
| Completed | Jiu-wei-zhen-xiao Granule for Advanced Hepatocellular Carcinoma Hepatocellular Carcinoma | EARLY_Phase 1 | 2019-04-07 |
| Unknown | Post-marketing Safety Surveillance of Xueshuantong-Injection : a Registry Study Adverse Drug Event, Adverse Drug Reactions, Anaphylactic Reaction | — | 2019-02-18 |
| Completed | Danshen-Jiang-Fu Granule Prepared by Danshen From Different Producing Areas for Primary Dysmenorrhea Primary Dysmenorrhea, Traditional Chinese Medicine | EARLY_Phase 1 | 2015-11-01 |
| Suspended | Post-marketing Safety Surveillance of Breviscapine Powder-Injection : a Registry Study Adverse Drug Event, Adverse Drug Reaction, Chinese Medicine | — | 2015-09-01 |
| Completed | Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study Safety Surveillance, Adverse Drug Events, Adverse Drug Reactions | — | 2014-09-01 |